Open an account

OrthoPediatrics

KIDS · NASDAQ

$23.50+$1.47 (+6.67%)TodayMarket closed ·
Prev close $22.03

About KIDS

OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. The company is headquartered in Warsaw Indiana, Indiana and currently employs 602 full-time employees. The company went IPO on 2017-10-12. The firm is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The firm sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. The company markets 80 surgical and specialized bracing systems.

Employees
602
Headquarters
Warsaw Indiana, Indiana
Listed
Oct 12, 2017
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
orthopediatrics.com

KIDS key statistics

Market cap
613.58M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
176.45K
Volume
233.31K
Open price
$22.27
High today
$23.54
Low today
$22.27
52 Week high
$26.74
52 Week low
$14.42

OrthoPediatrics (KIDS) at a glance

OrthoPediatrics (KIDS) last traded at $23.50, with a market cap of 613.58M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $22.27 and $23.54. The current price is 5.5% above the day's low and 0.2% below its high.

Volume so far is 233.31K shares, above the average of 176.45K shares a day.

Over the past year OrthoPediatrics has ranged from $14.42 to $26.74, and now sits 74% of the way up that range.

OrthoPediatrics met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported -$0.30 per share against an estimate of -$0.3085.

The average analyst price target is $27.77, 18.2% above the current price, from 6 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

83%of 6 analyst ratings say Buy
  • Buy83.3%
  • Hold16.7%
  • Sell0.0%
Price target · 11 analystsAvg $27.77
Low
$22.22
Now
$23.50
High
$36.75

KIDS earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 4.1% on average.

  1. Q3 FY24: reported -$0.34 per share against an estimate of -$0.2458
  2. Q4 FY24: reported -$0.69 per share against an estimate of -$0.3196
  3. Q1 FY25: reported -$0.46 per share against an estimate of -$0.4596
  4. Q2 FY25: reported -$0.30 per share against an estimate of -$0.3089
  5. Q3 FY25: reported -$0.50 per share against an estimate of -$0.2637
  6. Q4 FY25: reported -$0.43 per share against an estimate of -$0.343
  7. Q1 FY26: reported -$0.45 per share against an estimate of -$0.4827
  8. Q2 FY26: reported -$0.30 per share against an estimate of -$0.3085

KIDS news

  • OrthoPediatrics Q1 2026 Earnings Call: Complete Transcript

  • Beyond The Numbers: 5 Analysts Discuss OrthoPediatrics Stock

  • Demystifying OrthoPediatrics: Insights From 9 Analyst Reviews

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Earnings Scheduled For August 5, 2025

  • Demystifying OrthoPediatrics: Insights From 7 Analyst Reviews

  • Analyst Expectations For OrthoPediatrics's Future

  • Demystifying OrthoPediatrics: Insights From 4 Analyst Reviews

Similar companies

Companies in the same industry as OrthoPediatrics

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.